Fresenius Medical Care AG

FME

DE0005785802

Healthcare Facilities & Services

Real-time Estimate Tradegate Other stock markets 07:21:41 2024-04-25 am EDT			5-day change	1st Jan Change
38.44 ^EUR	-1.32%		+5.08%	+0.84%

Apr. 24	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
Apr. 23	FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research reiterates its Sell rating	ZD

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating

January 30, 2023 at 04:12 am EST

In his latest research note, analyst Hassan Al-Wakeel confirms his recommendation. The broker Barclays is keeping its Neutral rating. The target price is lowered from EUR 34 to EUR 32.

Latest news about Fresenius Medical Care AG

European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Apr. 24	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Warburg Research reiterates its Sell rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Deutsche Bank gives a Neutral rating	Apr. 23	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs keeps its Buy rating	Apr. 23	ZD
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	Apr. 22	MT
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	Apr. 22	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : DZ Bank sticks Neutral	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from Jefferies	Apr. 22	ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays gives a Neutral rating	Apr. 22	ZD
Berenberg rates FMC at 'Buy' - Target 47 euros	Apr. 22	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Buy rating from Berenberg	Apr. 22	ZD
Positive trend of FMC and Fresenius continues	Apr. 22	DP
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reiterates its Sell rating	Apr. 19	ZD
STOXX 600 nears six-week low on geopolitical jitters; Ericsson shines	Apr. 16	RE
Fresenius at a two-month high - Tyenne launch and fantasy figures	Apr. 16	DP
Fresenius at two-month high - Tyenne launch a milestone	Apr. 16	DP
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	Apr. 15	MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan gives a Sell rating	Apr. 04	ZD
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	Mar. 21	MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading	Mar. 19	MT
Fresenius Medical Care Launches Augmented Reality for Training on Kidney Replacement Therapy Device	Mar. 19	CI
Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar	Mar. 18	MT
Fresenius Settles With Johnson & Johnson to Market Stelara Alternative	Mar. 18	DJ
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading	Mar. 15	MT
Fresenius Medical Care AG Appoints Jörg Häring as New Global Head of Legal, Compliance and Human Resources and Also Assume the Role of Labor Director, Effective from June 1, 2024	Mar. 13	CI

Chart Fresenius Medical Care AG

Duration

Period

More charts

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Sector

Healthcare Facilities & Services

Calendar

2024-05-06 - Q1 2024 Earnings Call

Related indices

STOXX EUROPE 600 (EUR) , MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS MEDICAL CARE : Barebone 2023 profitability is a much lower starting point

February 21, 2024 at 04:12 am EST

More Strategies

Ratings for Fresenius Medical Care AG

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

38.96 EUR

Average target price

39.01 EUR

Spread / Average Target

+0.12%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS MEDICAL CARE AG	+0.84%	12.22B
CVS HEALTH CORPORATION	-14.17%	85.42B
HCA HEALTHCARE, INC.	+17.86%	84.38B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.39B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.51%	17.49B
FRESENIUS SE & CO. KGAA	-2.46%	16.44B
QUEST DIAGNOSTICS INCORPORATED	-0.24%	15.28B
EUROFINS SCIENTIFIC SE	-1.76%	11.71B
PURE HEALTH HOLDING	-31.23%	11.98B
DAVITA INC.	+26.71%	11.64B

Other Healthcare Facilities & Services

Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reiterates its Neutral rating

EPS Revisions